Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
about
Management of antiangiogenic therapy-induced hypertension.Regorafenib: a review of its use in previously treated patients with progressive metastatic colorectal cancer.Cardiovascular adverse effects of targeted antiangiogenic drugs: mechanisms and management.Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.Effect of high salt diet on blood pressure and renal damage during vascular endothelial growth factor inhibition with sunitinib.
P2860
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
@ast
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
@en
type
label
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
@ast
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
@en
prefLabel
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
@ast
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
@en
P2093
P2860
P356
P1476
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
@en
P2093
Benjamin D Humphreys
Emily Robinson
George Demetri
Michael C Heinrich
Nilka de Jesus-Gonzalez
Radostin Penchev
Suzanne George
William Tap
P2860
P304
P356
10.1038/AJH.2012.97
P577
2012-07-12T00:00:00Z